In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 166.8 | 118.4 | 143.0 | 128.3 | 190.2 | 174.5 | 183.1 | 156.6 | 135.6 | 278.0 | 306.1 | 360.7 | |
| Other Income | 0.8 | 0.5 | 0.4 | 0.5 | 1.4 | 3.1 | 0.0 | 0.6 | 3.7 | 2.4 | 16.4 | 7.9 | |
| Total Income | 167.7 | 118.9 | 143.4 | 128.8 | 191.6 | 177.6 | 183.1 | 157.2 | 139.3 | 280.4 | 322.5 | 368.6 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 80.1 | 59.1 | 81.5 | 69.6 | 88.2 | 96.0 | 95.7 | 92.8 | 81.8 | 163.9 | 165.0 | 204.3 | |
| + Changes in Inventories | 10.7 | -2.1 | -3.4 | -2.8 | 11.7 | -8.2 | -8.3 | -21.1 | -15.6 | -14.0 | 5.7 | -7.8 | |
| + Employee Benefit Expense | 23.4 | 24.0 | 25.4 | 28.0 | 29.9 | 31.3 | 34.5 | 34.3 | 33.3 | 40.2 | 43.0 | 46.5 | |
| + Finance Costs | 5.5 | 5.6 | 5.5 | 4.8 | 5.2 | 6.3 | 5.9 | 5.8 | 6.2 | 7.7 | 9.6 | 15.8 | |
| + Depreciation & Amortisation | 5.8 | 5.8 | 5.9 | 6.1 | 7.8 | 8.7 | 9.6 | 8.4 | 8.8 | 8.8 | 9.0 | 9.7 | |
| + Other Expenses | 16.5 | 13.6 | 21.2 | 16.8 | 23.6 | 22.1 | 27.0 | 22.2 | 19.1 | 23.8 | 30.6 | 32.6 | |
| Total Expenses | 142.0 | 106.0 | 136.2 | 122.6 | 166.3 | 156.2 | 164.5 | 142.4 | 133.6 | 230.5 | 262.9 | 301.2 | |
| EBITDA | 36.1 | 23.9 | 18.2 | 16.6 | 36.8 | 33.3 | 34.1 | 28.4 | 17.0 | 64.0 | 61.8 | 85.1 | |
| EBIT | 30.3 | 18.0 | 12.3 | 10.5 | 29.0 | 24.6 | 24.5 | 20.0 | 8.2 | 55.2 | 52.8 | 75.4 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 25.7 | 12.9 | 7.2 | 6.2 | 25.3 | 21.4 | 18.6 | 14.8 | 5.7 | 49.9 | 59.5 | 67.4 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.8 | 0.0 | 0.0 | |
| Pretax Income | 25.7 | 12.9 | 7.2 | 6.2 | 25.3 | 21.4 | 18.6 | 14.8 | 5.7 | 46.1 | 59.5 | 67.4 | |
| + Current Tax | 4.4 | 2.6 | 0.8 | 1.6 | 6.4 | 4.7 | 4.5 | 0.9 | 0.4 | 13.2 | 14.9 | 15.1 | |
| + Deferred Tax | 0.9 | -0.2 | 1.6 | 0.2 | 0.2 | 0.8 | 0.4 | 3.1 | 1.1 | -1.8 | 0.4 | 2.0 | |
| Tax Expense | 5.2 | 2.4 | 2.3 | 1.8 | 6.5 | 5.5 | 4.9 | 4.0 | 1.4 | 11.4 | 15.3 | 17.2 | |
| Net Income | 20.5 | 10.4 | 4.9 | 4.4 | 18.8 | 16.0 | 13.7 | 10.8 | 4.2 | 34.7 | 44.3 | 50.2 | |
| + Net Income — Continuing Ops | 20.5 | 10.4 | 4.9 | 4.4 | 18.8 | 16.0 | 13.7 | 10.8 | 4.2 | 34.7 | 44.3 | 50.2 | |
| + Other Comprehensive Income | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | -0.4 | 0.0 | |
| Total Comprehensive Income | 20.5 | 10.4 | 5.0 | 4.4 | 18.8 | 16.0 | 13.4 | 10.8 | 4.2 | 34.7 | 43.9 | 50.2 | |
| Per Share | |||||||||||||
| Basic EPS | 6.65 | 3.40 | 1.58 | 1.44 | 6.10 | 5.19 | 4.46 | 3.52 | 1.38 | 11.28 | 14.40 | 16.33 | |
| Diluted EPS | 6.65 | 3.40 | 1.58 | 1.44 | 6.10 | 5.19 | 4.46 | 3.52 | 1.38 | 11.28 | 14.40 | 16.33 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -0.3 | — | 0.0 | 0.0 | -0.4 | 0.0 | |
| + Items NOT to be Reclassified to P&L | — | — | — | — | — | — | -0.4 | — | — | — | — | — | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | -0.1 | — | 0.0 | 0.0 | 0.4 | 0.0 | |
| + Tax on Items NOT to be Reclassified — alt tag | — | — | -0.1 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 6.65 | 3.40 | 1.58 | 1.44 | 6.10 | 5.19 | 4.46 | 3.52 | 1.38 | 11.28 | 14.40 | 16.33 | |
| Diluted EPS — Continuing Operations | 6.65 | 3.40 | 1.58 | 1.44 | 6.10 | 5.19 | 4.46 | 3.52 | 1.38 | 11.28 | 14.40 | 16.33 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 76.0 | 61.4 | 64.8 | 61.4 | 90.3 | 86.7 | 95.7 | 84.9 | 69.4 | 128.1 | 135.4 | 164.2 | |
| Gross Margin % | 45.56 | 51.89 | 45.31 | 47.87 | 47.48 | 49.69 | 52.27 | 54.22 | 51.21 | 46.07 | 44.24 | 45.52 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 25.7 | 12.9 | 7.2 | 6.2 | 25.3 | 21.4 | 18.6 | 14.8 | 5.7 | 49.9 | 59.5 | 67.4 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.8 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | 20.5 | 10.4 | 4.9 | 4.4 | 18.8 | 16.0 | 13.7 | 10.8 | 4.2 | 37.5 | 44.3 | 50.2 | |
| EPS Adj | 6.65 | 3.40 | 1.58 | 1.44 | 6.10 | 5.19 | 4.46 | 3.52 | 1.38 | 12.20 | 14.40 | 16.33 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | 30.8 | |